A Study to Determine the Causes and Identify Increases in Influenza-Like Illness (ILI) in Mexico
NCT02378090 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 888
Last updated 2016-11-10
Summary
The purpose of this observational study is to characterize individuals in Mexico who seek medical care for influenza-like illness (ILI) and Severe Acute Respiratory Infection (SARI), describe seasonal pattern of the pathological agents associated with ILI and SARI and to identify changes in severity of disease caused by a specific agent.
Conditions
- Influenza Nos or Influenza-like Illness
- Acute Respiratory Infections
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
Coordinación de Investigación en Salud, Mexico
collaborator OTHER_GOV -
Mexican Emerging Infectious Diseases Clinical Research Network
lead NETWORK
Principal Investigators
-
Arturo Galindo-Fraga, MD · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
-
Daniel Noyola, MD · Hospital Central "Dr. Ignacio Morones Prieto"
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2016-11-30
- Completion
- 2016-11-30
Countries
- Mexico
Study Locations
More Related Trials
-
Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S.
NCT01262079 ·Status: COMPLETED
-
Mechanisms of Severe Acute Influenza Consortium (MOSAIC)
NCT00965354 ·Status: COMPLETED
-
Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children
NCT00985790 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults
NCT05827926 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
NCT00920374 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerability and Measurability of the Efficacy of Non Pharmaceutical Measures to Prevent Seasonal Influenza
NCT00833885 ·Status: COMPLETED ·Phase: NA
-
Influenza Vaccination Among the Elderly Individuals
NCT02362919 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
NCT06178991 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a Screen and Treat Protocol for Influenza
NCT06207058 ·Status: TERMINATED
-
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
NCT01560793 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults
NCT05875961 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico.
NCT02255279 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States
NCT02019732 ·Status: COMPLETED
-
Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1
NCT00989274 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine
NCT01072799 ·Status: COMPLETED ·Phase: PHASE2
-
Prophylactic Efficacy of Relenza Against Influenza A and B
NCT01156701 ·Status: COMPLETED
-
Virus Shedding and Environmental Deposition of a Novel Influenza Virus
NCT01046734 ·Status: COMPLETED
-
The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination
NCT02876159 ·Status: COMPLETED ·Phase: PHASE4
-
Seasonal Influenza Vaccine Effectiveness Study in Kenya
NCT01432340 ·Status: COMPLETED
-
A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults
NCT05333289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)
NCT04664075 ·Status: TERMINATED
-
Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults
NCT00975884 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects
NCT00518726 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults
NCT06680375 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
NCT06683352 ·Status: COMPLETED ·Phase: PHASE1/PHASE2